Fosamax Warning Issued by FDA
Fosamax an osteoporotic prescription drug is in the class of drugs known as bisphosphonates. Fosamax changes the cycle of bone remodeling by slowing down bone loss while bone mass is increased. This drug is used to treat osteoporosis that is steroid-induced or post-menopausal in nature and can also be prescribed for Paget’s disease which is an abnormal bone formation. Fosamax may help to prevent fractures of the wrist, spinal vertebrae and hip. Fosamax has been associated with a number of side effects including osteonecrosis of the jaw (ONJ), severe bone or joint pain, femur fractures and esophageal ulcerations. These Fosamax side effects may be a prelude to a Fosamax Recall, although only a warning has been issued. These side effects have initiated a Fosamax Lawsuit against Merck the manufacturer of this osteoporotic drug.
Fosamax Lawsuits Filed A Cross Country
A number of warnings have been added to Fosamax packaging as reports of side effects began to accumulate over time. In 2004, the Food and Drug Administration (FDA) required Merck to include a warning label to alert patients of the risk of ONJ due to reports of the possible link between Fosamax and osteonecrosis of the jaw. Osteonecrosis of the jaw is a destruction of the bone tissue in the jaw that can lead to infection, jawbone breakdown, ulcers in the mouth or osteomyelitis (inflammation of the bone marrow). These reports have brought about a Fosamax Lawsuit involving ONJ. In January of 2008, the FDA issued an alert to inform consumers of the possibility of severe bone, joint and/or muscle pain in consumers taking Fosamax. This pain may occur within day, months or years of taking this osteoporotic drug. These reports have brought about a Fosamax Lawsuit involving bone, joint and muscle pain. Then by April of 2008, new studies were linking Fosamax to serious atrial fibrillation (irregular heart beat) in women. In October 2010, the FDA requested that Merck place a femur fracture warning label be added to all bisphosphonate drugs including Fosamax. However, Merck does not admit to a cause and effect relationship between Fosamax and femur fractures. Although there is evidence that suggests that there is a connection between Fosamax and femur fracture for some time, Merck has still failed to adequately warn consumers of this osteoporotic drug. With all this FDA attention, it is possible that there may be a Fosamax Recall in the near future.
The FDA recommends that consumers taking Fosamax or other bisphosphonates should review the new medication guide for all symptoms involved with this drug. You should notify your healthcare provider if you experience any side effects immediately. The FDA is continuing to review the possible connection between Fosamax and femur fractures and recommends that all patients continue to take their medication unless told they should stop by their physician. The FDA also urges patients to report any Fosamax side effects including femur fractures through the FDA’s MedWatch program. This close scrutiny by the FDA indicates a possible Fosamax Recall in the future. Make sure to keep abreast of new Fosamax news to check for additional side effects and a possible Fosamax Recall.
Contact a Lawyer with Expertise in the Fosamax Lawsuit
If you have experienced any Fosamax complications such as a femur fracture or any other Fosamax side effect you might want to contact a Fosamax attorney to see if you qualify for a Fosamax Lawsuit. As with any defective product, there is a limited time when you can claim a Fosamax Lawsuit. And, remember to keep yourself informed about a possible Fosamax Recall.
You May be entitled to Compensation, so act now.
Call us now at 877-222-7069 or use the contact form for a free case review.
The FDA annouced on July 6th, that Stryker has announced a voluntary recall of its modular neck...
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the...
Innovative Surgical, the manufacture of the Da Vinci Surgery Robot recieved a warning letter from FDA...
ATTORNEY ADVERTISEMENT— The information provided on RecallWarning.com is not a substitute for professional medical or legal advice, diagnosis or treatment. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form does not form an attorney-client relationship with the sponsoring attorney. This website is independent of the FDA or any other medical or Govenmental organization. Information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider.
RecallWarning.com is owned and operated by ProSoftLabs
Let Us Help!